eisai co ltd (4523:Tokyo Stock Exchange)
Chief Commercial Officer-Oncology Business, SVP, President-EMEA & Eisai Global Oncology Business,Eisai Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2017
Gary Hendler serves as Chief Commercial Officer of Oncology Business Group at Eisai Inc. Gary Hendler serves as Senior Vice President at Eisai Co., Ltd. Gary Hendler serves as Chief Executive Officer of Eisai Europe Ltd, President of Eisai Europe Ltd, President of EMEA Region and President of Eisai Global Oncology Business Unit. Gary Hendler served as Vice President of Eisai Co. Ltd. since June 18, 2010 and serves as its President of EMEA Region. Gary Hendler serves ...
4-6-10, KoishikawaPhone: 81 3 3817 3016
Tokyo, -- 112-8088
Fax: 81 3 3811 6032
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Jeffrey Marc Leiden||Chairman, CEO & President|
Vertex Pharmaceuticals Incorporated
|David D. Meek||CEO & Director|
|Hervé Hoppenot||Chairman of the Board, President & CEO|
|Bruce C. Cozadd||Co-Founder, Executive Chairman & CEO|
Jazz Pharmaceuticals plc
|Sigurdur Oli Olafsson Ph.D.||CEO & Executive Director|
Hikma Pharmaceuticals PLC
|--||Compensation as of Fiscal Year --.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.